Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hironobu Sugita

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 16, 2005
[Clinicopathologic study of 50 autopsy cases of idiopathic pulmonary fibrosis and non-diffuse usual interstitial pneumonia]Kazuo Fukushima, Yoshinori Kawabata, Takashi Uchiyama, et al.
Biochemical and Biophysical Research Communications|October 28, 2008
A new evaluation method for quantifying PI3K activity by HTRF assayHironobu Sugita, Shingo Dan, Dexin Kong, et al.
Kekkaku : [Tuberculosis]|March 4, 2015
[Association between smoking and tuberculosis infection]Hitoshi Tagawa, Hironobu Sugita, Tomoaki Nakazono, et al.
Kekkaku : [Tuberculosis]|February 22, 2007
[Adverse effect other than liver dysfunction in treatment of latent tuberculous infection by isoniazid]Kunihiko Ito, Hitoshi Hoshino, Tomoaki Nakazono, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2020
Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancerRie Horii, Hitoshi Tsuda, Shinobu Masuda, et al.
Kekkaku : [Tuberculosis]|December 13, 2006
[Liver damage in treatment of latent tuberculous infection by isoniazid]Kunihiko Ito, Hitoshi Hoshino, Tomoaki Nakazono, et al.
Kekkaku : [Tuberculosis]|March 17, 2011
[Liver dysfunction during treatment of latent tuberculosis infection]Tomoaki Nakazono, Naoko Tezuka, Hitoshi Tagawa, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|March 1, 2006
[Clinical studies on the pathogenetic factors of cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease]Masao Okumura, Kazuro Iwai, Hideo Ogata, et al.
Cancer Research|June 10, 2010
Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluationsShingo Dan, Mutsumi Okamura, Mariko Seki, et al.
Molecular and Clinical Oncology|July 14, 2022
Comparison between a new assay system, Elecsys<sup>®</sup> Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional studyTakashi Suzuki, Yoko Oshima, Fumiaki Shiratori, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 16, 2005
[Clinicopathologic study of 50 autopsy cases of idiopathic pulmonary fibrosis and non-diffuse usual interstitial pneumonia]Kazuo Fukushima, Yoshinori Kawabata, Takashi Uchiyama, et al.
Biochemical and Biophysical Research Communications|October 28, 2008
A new evaluation method for quantifying PI3K activity by HTRF assayHironobu Sugita, Shingo Dan, Dexin Kong, et al.
Kekkaku : [Tuberculosis]|March 4, 2015
[Association between smoking and tuberculosis infection]Hitoshi Tagawa, Hironobu Sugita, Tomoaki Nakazono, et al.
Kekkaku : [Tuberculosis]|February 22, 2007
[Adverse effect other than liver dysfunction in treatment of latent tuberculous infection by isoniazid]Kunihiko Ito, Hitoshi Hoshino, Tomoaki Nakazono, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2020
Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancerRie Horii, Hitoshi Tsuda, Shinobu Masuda, et al.
Kekkaku : [Tuberculosis]|December 13, 2006
[Liver damage in treatment of latent tuberculous infection by isoniazid]Kunihiko Ito, Hitoshi Hoshino, Tomoaki Nakazono, et al.
Kekkaku : [Tuberculosis]|March 17, 2011
[Liver dysfunction during treatment of latent tuberculosis infection]Tomoaki Nakazono, Naoko Tezuka, Hitoshi Tagawa, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|March 1, 2006
[Clinical studies on the pathogenetic factors of cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease]Masao Okumura, Kazuro Iwai, Hideo Ogata, et al.
Cancer Research|June 10, 2010
Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluationsShingo Dan, Mutsumi Okamura, Mariko Seki, et al.
Molecular and Clinical Oncology|July 14, 2022
Comparison between a new assay system, Elecsys<sup>®</sup> Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional studyTakashi Suzuki, Yoko Oshima, Fumiaki Shiratori, et al.
Pageof 2